Ultra-low-field MRI operated during particle delivery without relevant dosimetric disruption
A portable 49 mT MRI system operated during proton and carbon-ion delivery with stable imaging and minimal dosimetric impact.
A portable 49 mT MRI system operated during proton and carbon-ion delivery with stable imaging and minimal dosimetric impact.
Per-fraction MR radiomics identified distinct tumor and healthy-liver trajectories during SBRT that were not explained by volume or dose alone.
All 15 replans met target coverage, but one-third exceeded at least one bowel objective and kidney constraints remained challenging.
PET/CT reduced mean PTV by 149 cm³ while identifying substantial disease outside CT-based targets in 20% of patients.
Three commercial AI models produced broadly usable head-and-neck contours, reducing review time to five minutes, but anatomical definitions differed importantly between vendors.
Clinicians applying dose-equivalence models to identical scenarios agreed only 25.8%, exposing major variability in treatment gaps, hypofractionation and reirradiation.
A deep-learning model ordered first-to-last fraction images with 95% accuracy, while smaller longitudinal changes were associated with later biochemical recurrence.
Adaptation preserved prescription-level D99 in all 50 fractions, while a 1-mm margin achieved 98% despite minimal daily dose perturbation.
A 1.5–3.0 mm foam elevation reduced marker contouring time by 30–37% while keeping average positional error near 1 mm.
A 3-mm grid cut Monaco calculation time about threefold but altered target, conformity and dose-falloff metrics despite similar gamma QA.
UTE-MRI-derived synthetic CT produced <1% target-dose differences and a 95.4% gamma pass rate at 2%/2 mm.
MRI-based nnU-Net segmentation achieved Dice scores ≥0.90 and reduced clinical contouring workflow time by more than 50%.
Low-cost acrylic and beeswax thorax phantoms produced dose measurements comparable with a commercial phantom and generally remained within IAEA tolerance.
Four quality-improvement measures reduced >3-mm chest-wall errors from 21.2% to 4.7%, but sternal marker placement increased skin reactions.
Interplay-related underdosage largely disappeared after five fractions, although two high-motion plans retained clinically relevant target deficits.